Jiangsu Sumei Pharmaceutical Group

Founded in 1972, Jiangsu Sumei Pharmaceutical Group is a new-type health industry group that develops in sync with China's pharmaceutical industry and aligns with international pharmaceutical standards, integrating pharmaceutical manufacturing, pharmaceutical commercial sales, and health industry. It has been established as a key high-tech enterprise under the National Torch Plan, one of the top 100 pharmaceutical manufacturing enterprises in China, a contract-abiding and credit-worthy enterprise, one of the first innovative enterprises in Jiangsu Province, and a key backbone enterprise of the Taizhou Pharmaceutical Industry Base under the National Torch Plan.
For over fifty years, Sumei Pharmaceutical has adhered to a clinical value-oriented approach and patient health-centered principle, catering to the full-cycle health needs of the entire population from prevention, treatment to rehabilitation and health maintenance. It has built three full industry chain systems covering pharmaceuticals, medical devices, and health products. The group has 12 wholly-owned holding companies, including Taizhou Pharmaceutical, Sumei Biologics, Sumei R&D, Kangsier Technology, Sumei Health, and Sumei Medical Devices, with its headquarters in Taizhou City, Jiangsu Province, employing over 3,000 people.
The company focuses on building advanced manufacturing capabilities, establishing R&D and production bases for traditional Chinese and Western medicines, medical devices, and health products. It emphasizes the development of pharmaceutical groups for kidney and endocrine diseases, maternal and child health, respiratory and digestive diseases, and cardiovascular and cerebrovascular diseases. It also develops high-end medical device product lines such as blood purification, wound management, and ultra-fine endoscopes, as well as a large health product library including traditional Chinese medicine daily chemicals, special medical foods, and health supplements. Among them, the national essential drug list's Shengmai Injection, exclusive specialty products such as Huangkui Capsule, Danlu Capsule, Zhichuanling Injection, Zhichuanling Oral Liquid, Qingxuan Zhike Granules, Pushen Capsule, Compound Wusheng Huaguo Lozenges, etc., sell well nationwide. Devices led by negative pressure drainage sponge and breast duct endoscopy, as well as health products mainly including Huangkui Yikou Qing toothpaste and low-gluten protein rice, inject continuous momentum into the company's sustainable and high-quality development. In addition, the company has obtained product registration approvals in Malaysia and Indonesia, taking a solid step forward in the internationalization of traditional Chinese medicine.
The company always regards self-reliance and self-improvement in science and technology as strategic support for high-quality development. With the Sumei Research Institute as the innovation carrier, it has established a post-doctoral scientific research workstation (awarded by the Ministry of Personnel of the People's Republic of China and the National Postdoctoral Management Committee), and the Jiangsu Provincial Kidney Disease Drug Engineering Technology Research Center. It collaborates closely with domestic and international institutions such as the Chinese Academy of Sciences, Zhejiang University, China Pharmaceutical University, Nanjing University of Chinese Medicine, and the Paris Public Hospital Group in France. It has undertaken 3 national major new drug innovation projects, 4 National Torch Plan projects, 1 national traditional Chinese medicine planting project, 4 Jiangsu Province scientific and technological achievement transformation projects, and dozens of provincial and municipal key scientific and technological projects, and has obtained nearly 100 authorized invention patents. In 2016, the company's star product, Huangkui Capsule, was awarded the first prize of the National Science and Technology Progress Award.
Sumei Pharmaceutical adheres to the corporate spirit of "Sumei nourishes all things, flourishing in China" and social responsibility, upholding the corporate mission of "creating health with science and technology," deeply practicing the core values of "integrity, pragmatism, inheritance, and innovation," continuously delivering premium health products, extensively disseminating health culture, actively optimizing health services, and unswervingly contributing to the well-being of all people. It is committed to building a century-old brand and helping realize the dream of a healthy China!